FindTrial
Sign In

Patient trial to verify if Diabetran helps treat wounds, protect injured skin, and ease bandage application

Single-blind clinical study on the efficacy and safety of the product Diabetran

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-10zb5s89
Enrollment
Unknown
Registered
2024-11-18
Start date
2024-05-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds Penetrating

Interventions

Proof of the efficacy and safety of the product Diabetran. It is indicated to aid in the treatment of lesions and protect the skin after injuries and cuts. It safeguards the skin prior to the applicat
E05.940.790.500

Sponsors

Nipo Serviços Médicos SS Ltda
Lead Sponsor
Instituto de Saúde e Bem Estar da Mulher
Collaborator

Eligibility

Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: The participating patient has a wound, lesion, or bedsore. The injury requires dressings. Age between 18 and 90 years old. Any ethnicity, color/race, and skin phototype. Both genders. Patients are in the early stages of treatment

Exclusion criteria

Exclusion criteria: Pregnancy. Neonates. Sensitivity to the components of the medication

Design outcomes

Primary

MeasureTime frame
To prove the efficacy and safety of Diabetran in humans affected by chronic or acute wounds and to demonstrate the product's effectiveness in assisting the treatment of lesions—

Secondary

MeasureTime frame
To demonstrate that other skin conditions may also benefit from the product with equal efficacy—

Countries

Brazil

Contacts

Public ContactFrederico Viana

TCI Laboratório Biotecnológico Ltda

frederico@tcilab.com.br+55 38 99886-3565

Outcome results

None listed

Source: REBEC (via WHO ICTRP)